
More than 500,000 of the new kit from Quest Diagnostics will be made available by the end of June.

More than 500,000 of the new kit from Quest Diagnostics will be made available by the end of June.

In an interview with CNN, the head of the National Institute of Allergy and Infectious Disease seemed optimistic about the truncated timeline.

The move will bring the out-of-pocket cost down to a maximum of $35 for a month supply starting in plan year 2021, according to CMS.


Nearly half of adults have deferred some medical care.

In a letter to the U.S. Department of Health and Human Services, the group says primary care physicians need the same help as rural hospitals.



Nearly half of the survey respondents say they have used telehealth services and there appears to be an appetite for the services after the current pandemic.

The company is required to deliver 400 million doses, but they have capacity for one billion doses through 2020 into 2021.

While patient volumes are up from early April, they are still about one-third of what they were before the pandemic.

The stress of the pandemic is taking its toll.



The standalone collection kit can be used with certain authorized tests.

Some states are more vulnerable to the pandemic than others.

In a letter to congressional leaders, the ACP offered support on many provisions of the HEROES Act.

The Student Loan Forgiveness for Frontline Health Workers Act is currently in committee.


A pair of guidance documents seek to streamline the process of submitting applications to initiate clinical studies and give recommendation for designing clinical trials.


The lag in patient volume could take between one and six months.


The agency seeks to tamp down on unscrupulous companies exploiting the pandemic.


A majority of respondents say it’s unlikely for them to visit a hospital during the pandemic for a reason unrelated to COVID-19.

Farxiga oral tablets have been approved for adults with heart failure with reduced ejection fraction.


The updated rule allows companies to develop and distribute the tests after validation while an emergency use authorization is being prepared for submission.

The technology enables physicians to instantly video call their patients from a smartphone.